KELLY BATTEN: Open Payments
NPI 1902464977 · NOBLESVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,127 in 58 payments from 15 companies in 2025. Trend: 2023 $1,067 · 2024 $1,345 · 2025 $1,127
Food & beverage: $1,127
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $226 |
| Otsuka America Pharmaceutical, Inc. | 11 | $158 |
| Neurocrine BioSciences, Inc. | 5 | $98 |
| ABBVIE INC. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 3 | $64 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
Products named: CAPLYTA, REXULTI, FANAPT, HETLIOZ, INGREZZA, VRAYLAR, SPRAVATO, Auvelity.
Industry payments across IN — which companies pay providers there.
